title: Comparative effects of oyster mushrooms on lipid profile, liver and kidney function in hypercholesterolemic rats.
abstract: Comparative effects of oyster mushrooms on plasma and fecal lipid profiles and on liver and kidney function were evaluated in hyper and normocholesterolemic rats. Feeding of hypercholesterolemic rats a 5% powder of oyster mushrooms (Pleurotus ostreatus, P. sajor-caju and P. florida) reduced the plasma total cholesterol level by 37%, 21% and 16%, respectively and reduced the triglyceride level by 45%, 24% and 14%, respectively. LDL/HDL ratio decreased by 64%, 45% and 41% for P. sajor-caju, P. ostreatus and P. florida fed rats, respectively. Mushroom feeding also reduced body weight in hypercholesterolemic rats. However, it had no adverse effect on plasma bilirubin, creatinin and urea nitrogen level. Mushroom feeding also increased the total lipid and cholesterol excretion in the feces. The present study reveals that feeding of 5% oyster mushroom powder does not have detrimental effects on the liver and kidneys rather may provide health benefits for the cardiovascular-related complication by decreasing the atherogenic lipid profiles.
authors: Department of Biology, University of Incheon, Incheon 402-749, Korea. ; Department of Botany, Jahangirnagar University, Savar, Dkaka-1342, Bangladesh.
authors: Nuhu
authors: N
authors: Alam
authors: Ruhul
authors: R
authors: Amin
authors: Asaduzzaman
authors: A
authors: Khan
authors: Ismot
authors: I
authors: Ara
authors: Mi Ja
authors: MJ
authors: Shim
authors: Min Woong
authors: MW
authors: Lee
authors: U Youn
authors: UY
authors: Lee
authors: Tae Soo
authors: TS
authors: Lee
keywords: Hypercholesterolemic rats; Lipid profile; Liver and kidney function; Oyster mushrooms
references: Life Sci. 1999;64(2):135-43
references: 10069491
references: J Vasc Res. 1998 Jan-Feb;35(1):55-62
references: 9482696
references: J Lipid Res. 2001 Jul;42(7):1160-8
references: 11441145
references: Physiol Res. 1993;42(6):175-9
references: 7710476
references: J Biol Chem. 1992 Mar 15;267(8):5584-91
references: 1544932
references: J Biol Chem. 1957 May;226(1):497-509
references: 13428781
references: Jpn J Pharmacol. 1996 Jun;71(2):113-8
references: 8835637
references: Experientia. 1995 Jun 14;51(6):589-91
references: 7607302
references: J Nutr. 1999 Jan;129(1):70-6
references: 9915878
references: Nutr Rev. 1996 Nov;54(11 Pt 2):S91-3
references: 9110582
references: Neuroscience. 1999;93(1):237-41
references: 10430487
references: J Nutr Sci Vitaminol (Tokyo). 1987 Oct;33(5):341-6
references: 3443885
references: Biochim Biophys Acta. 1976 Jul 20;441(1):155-64
references: 952982
references: World Rev Nutr Diet. 1997;82:XII-XIV, 1-266
references: 9312944
references: J Neurochem. 1999 Mar;72(3):1133-8
references: 10037485
references: Carbohydr Res. 1985 Jul 1;140(1):93-100
references: 4053098
references: Lipids. 2001;36 Suppl:S65-8
references: 11837995
references: Clin Exp Pharmacol Physiol. 2001 Apr;28(4):266-70
references: 11251638
references: Pharmacol Toxicol. 1996 Dec;79(6):318-23
references: 9000259
references: AMA Arch Pathol. 1954 Apr;57(4):333-51
references: 13147645
references: Biochim Biophys Acta. 1995 Jan 3;1254(1):7-12
references: 7811749
references: J Exp Med. 1956 Oct 1;104(4):539-54
references: 13367329
references: J Nutr. 2000 Sep;130(9):2151-6
references: 10958806
references: Biochim Biophys Acta. 1993 Oct 13;1170(2):165-72
references: 8399341
references: FEMS Microbiol Lett. 1993 Nov 1;113(3):333-7
references: 8270199
references: Am J Physiol. 1999 Mar;276(3):H970-5
references: 10070081
references: J Lipid Res. 1983 May;24(5):541-51
references: 6875379